Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 106
of 6Next
1:

Spatial clustering of filarial transmission before and after a Mass Drug Administration in a setting of low infection prevalence.

Washington CH, Radday J, Streit TG, Boyd HA, Beach MJ, Addiss DG, Lovince R, Lovegrove MC, Lafontant JG, Lammie PJ, Hightower AW.

Filaria J. 2004 May 5;3(1):3.

PMID: 15128461 [PubMed - as supplied by publisher]

2:

Longitudinal analysis of the development of filarial infection and antifilarial immunity in a cohort of Haitian children.

Lammie PJ, Reiss MD, Dimock KA, Streit TG, Roberts JM, Eberhard ML.

Am J Trop Med Hyg. 1998 Aug;59(2):217-21.

PMID: 9715935 [PubMed - indexed for MEDLINE]

3:

Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment.

Ramzy RM, El Setouhy M, Helmy H, Ahmed ES, Abd Elaziz KM, Farid HA, Shannon WD, Weil GJ.

Lancet. 2006 Mar 25;367(9515):992-9. Erratum in: Lancet. 2006 Jun 17;367(9527):1980.

PMID: 16564361 [PubMed - indexed for MEDLINE]

4:

The effect of repeated half-yearly diethylcarbamazine mass treatment on Wuchereria bancrofti infection and transmission in two East African communities with different levels of endemicity.

Simonsen PE, Meyrowitsch DW, Mukoko DA, Pedersen EM, Malecela-Lazaro MN, Rwegoshora RT, Ouma JH, Masese N, Jaoko WG, Michael E.

Am J Trop Med Hyg. 2004 Jan;70(1):63-71.

PMID: 14971700 [PubMed - indexed for MEDLINE]

6:

The effect of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination.

Ramaiah KD, Vanamail P, Pani SP, Yuvaraj J, Das PK.

Trop Med Int Health. 2002 Sep;7(9):767-74.

PMID: 12225508 [PubMed - indexed for MEDLINE]

7:

The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration.

de Rochars MB, Kanjilal S, Direny AN, Radday J, Lafontant JG, Mathieu E, Rheingans RD, Haddix AC, Streit TG, Beach MJ, Addiss DG, Lammie PJ.

Am J Trop Med Hyg. 2005 Nov;73(5):888-94.

PMID: 16282299 [PubMed - indexed for MEDLINE]

8:

Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs.

De Rochars MB, Direny AN, Roberts JM, Addiss DG, Radday J, Beach MJ, Streit TG, Dardith D, Lafontant JG, Lammie PJ.

Am J Trop Med Hyg. 2004 Oct;71(4):466-70.

PMID: 15516644 [PubMed - indexed for MEDLINE]

9:

PCR and Mosquito dissection as tools to monitor filarial infection levels following mass treatment.

Goodman DS, Orelus JN, Roberts JM, Lammie PJ, Streit TG.

Filaria J. 2003 Jul 7;2(1):11.

PMID: 12890288 [PubMed - as supplied by publisher]

10:

The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia.

Rajendran R, Sunish IP, Mani TR, Munirathinam A, Abdullah SM, Augustin DJ, Satyanarayana K.

Ann Trop Med Parasitol. 2002 Sep;96(6):595-602.

PMID: 12396322 [PubMed - indexed for MEDLINE]

11:

Th1-like antifilarial immune responses predominate in antigen-negative persons.

Dimock KA, Eberhard ML, Lammie PJ.

Infect Immun. 1996 Aug;64(8):2962-7.

PMID: 8757821 [PubMed - indexed for MEDLINE]

12:

Endpoints for lymphatic filariasis programs.

Grady CA, de Rochars MB, Direny AN, Orelus JN, Wendt J, Radday J, Mathieu E, Roberts JM, Streit TG, Addiss DG, Lammie PJ.

Emerg Infect Dis. 2007 Apr;13(4):608-10.

PMID: 17553278 [PubMed - indexed for MEDLINE]

13:

Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes.

Bockarie MJ, Alexander ND, Hyun P, Dimber Z, Bockarie F, Ibam E, Alpers MP, Kazura JW.

Lancet. 1998 Jan 17;351(9097):162-8.

PMID: 9449870 [PubMed - indexed for MEDLINE]

14:

Reduced antifilarial IgG4 responsiveness in a subpopulation of microfilaremic persons.

Marley SE, Lammie PJ, Eberhard ML, Hightower AW.

J Infect Dis. 1995 Dec;172(6):1630-3.

PMID: 7594734 [PubMed - indexed for MEDLINE]

15:

Persistence of parasite antigenemia following diethylcarbamazine therapy of bancroftian filariasis.

Weil GJ, Sethumadhavan KV, Santhanam S, Jain DC, Ghosh TK.

Am J Trop Med Hyg. 1988 May;38(3):589-95.

PMID: 3079315 [PubMed - indexed for MEDLINE]

16:

Progression of lymphatic vessel dilatation in the presence of living adult Wuchereria bancrofti.

Dreyer G, Addiss D, Roberts J, Norões J.

Trans R Soc Trop Med Hyg. 2002 Mar-Apr;96(2):157-61.

PMID: 12055805 [PubMed - indexed for MEDLINE]

17:

Evaluation of the whole blood filariasis ICT test for short-term monitoring after antifilarial treatment.

Schuetz A, Addiss DG, Eberhard ML, Lammie PJ.

Am J Trop Med Hyg. 2000 Apr;62(4):502-3.

PMID: 11220767 [PubMed - indexed for MEDLINE]

18:

Mass treatment to eliminate filariasis in Papua New Guinea.

Bockarie MJ, Tisch DJ, Kastens W, Alexander ND, Dimber Z, Bockarie F, Ibam E, Alpers MP, Kazura JW.

N Engl J Med. 2002 Dec 5;347(23):1841-8.

PMID: 12466508 [PubMed - indexed for MEDLINE]

19:

Situation analysis in a large urban area of India, prior to launching a programme of mass drug administrations to eliminate lymphatic filariasis.

Ramaiah KD, Vijay Kumar KN, Ravi R, Das PK.

Ann Trop Med Parasitol. 2005 Apr;99(3):243-52.

PMID: 15829134 [PubMed - indexed for MEDLINE]

20:

Immuno-parasitological assessment of bancroftian filariasis in a highly endemic area along the River Sabaki, in Malindi district, Kenya.

Njenga SM, Wamae CN, Mwandawiro CS, Molyneux DH.

Ann Trop Med Parasitol. 2007 Mar;101(2):161-72.

PMID: 17316502 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 106
of 6Next